[Mechanism of increased glycogenolytic effect of diazoxide in potassium deficiency].
D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D003981:Diazoxide / Q000494:pharmacology; D004798:Enzymes; D004950:Esterases; D005964:Glucosyltransferases; D006943:Hyperglycemia; D011189:Potassium Chloride / Q000494:pharmacology*; D011191:Potassium Deficiency / Q000150:complications*; D051381:Rats; D012964:Sodium / Q000378:metabolism*
D000959:Antihypertensive Agents; D004798:Enzymes; D011189:Potassium Chloride; D012964:Sodium; D005964:Glucosyltransferases; D004950:Esterases; D003981:Diazoxide
Mechanismus der gesteigerten glykogenolytischen Wirkung des Diazoxids im Kaliummangel.